Skip to Content

Multikinase inhibitors

What are Multikinase inhibitors

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

List of Multikinase inhibitors:

Filter by:
Drug NameView by: Brand | Generic Reviews Avg. Ratings
crizotinib systemic (Pro, More...)
3 reviews
   
9.3
dabrafenib systemic (Pro, More...)
1 review
   
9.0
trametinib systemic (Pro, More...)
1 review
   
9.0
midostaurin systemic (Pro, More...)
1 review
   
8.0
afatinib systemic (Pro, More...)
2 reviews
   
7.5
sunitinib systemic (Pro, More...)
20 reviews
   
7.4
sorafenib systemic (Pro, More...)
11 reviews
   
7.0
ibrutinib systemic (Pro, More...)
13 reviews
   
6.6
vemurafenib systemic (Pro, More...)
4 reviews
   
6.6
ruxolitinib systemic (Pro, More...)
5 reviews
   
6.2
axitinib systemic (Pro, More...)
0 reviews
   
6.0
regorafenib systemic (Pro, More...)
3 reviews
   
5.5
ceritinib systemic (Pro, More...)
1 review
   
5.0
ponatinib systemic (Pro, More...)
2 reviews
   
3.0
cabozantinib systemic (Pro, More...)
1 review
   
1.0
alectinib systemic (Pro, More...)
0 reviewsAdd rating
brigatinib systemic (Pro, More...)
0 reviewsAdd rating
cobimetinib systemic (Pro, More...)
0 reviewsAdd rating
lenvatinib systemic (Pro, More...)
0 reviewsAdd rating
nintedanib systemic (Pro, More...)
0 reviewsAdd rating
vandetanib systemic (Pro, More...)
0 reviewsAdd rating
Hide